POOR ERYTHROID ENGRAFTMENT

Clinical trials for POOR ERYTHROID ENGRAFTMENT explained in plain language.

Never miss a new study

Get alerted when new POOR ERYTHROID ENGRAFTMENT trials appear

Sign up with your email to follow new studies for POOR ERYTHROID ENGRAFTMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug aims to stop post-transplant anemia in high-risk blood cancer patients

Disease control Not yet recruiting

This study tests whether the drug luspatercept can prevent severe anemia (low red blood cells) after a stem cell transplant in people with blood cancers who also have moderate to severe myelofibrosis (scarring in the bone marrow). About 196 adults aged 18-65 will be randomly assi…

Matched conditions: POOR ERYTHROID ENGRAFTMENT

Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated May 26, 2026 11:11 UTC

POOR ERYTHROID ENGRAFTMENT

Get alerted when new POOR ERYTHROID ENGRAFTMENT trials appear

New drug aims to stop post-transplant anemia in high-risk blood cancer patients